Product Identifier: KETALEAN®
DIN #: 00612316
MATERIAL SAFETY DATA SHEET SECTION 1 – PRODUCT IDENTIFICATION AND USE MANUFACTURER’S NAME:
BIMEDA-MTC ANIMAL HEALTH INC.
SUPPLIER’S NAME:
BIMEDA-MTC ANIMAL HEALTH INC.
STREET ADDRESS:
420 BEAVERDALE ROAD
STREET ADDRESS:
420 BEAVERDALE ROAD
CITY AND PROVINCE:
CAMBRIDGE, ONTARIO
CITY AND PROVINCE:
CAMBRIDGE, ONTARIO
POSTAL CODE:
N3C 2W4
POSTAL CODE:
N3C 2W4
TELEPHONE #
519-654-8000
TELEPHONE #
519-654-8000
EMERGENCY RESPONSE:
CHEMTREC
TELEPHONE #
1-800-424-9300
CHEMICAL NAME: PRODUCT USE:
CHEMICAL FAMILY:
CHEMICAL FORMULA:
Veterinary Injection for Intramuscular Use. Used for restraint or as the sole anesthetic agent for diagnostic or minor, brief surgical procedures in cats and subhuman primates only.
PRODUCT CODE: T002
PRODUCT SIZE:
50 mL
SECTION 2 – ACTIVE INGREDIENTS INGREDIENT NAME
CAS NUMBER
SYNONYMS
CONCENTRATION
* Ketamine Hydrochloride Water for Injection Benzethonium Chloride (as preservative)
1867-66-9 7732-18-5 121-54-0
Vetalar WFI Benzethonium
100 mg/mL Balance 0.1 mg/mL
SECTION 3 – PHYSICAL DATA PHYSICAL STATE:
ODOUR AND APPEARANCE:
Liquid
Pale yellow, clear liquid with minimal odour.
ODOUR THRESHOLD (ppm):
VAPOUR PRESSURE (mm Hg):
VAPOUR DENSITY (Air = 1):
VISCOSITY:
Not established
Not established
Not established
BOILING POINT (DEG.C):
MELTING POINT (DEG. C):
DECOMPOSITION TEMPERATURE:
Not established
Not established
Not established
pH (100%):
SPECIFIC GRAVITY/DENSITY:
SOLUBIITY IN WATER:
OTHER SOLVENTS:
3.5 – 5.5
Not established
Complete
Not established
SECTION 4 – HAZARDOUS IDENTIFICATION EMERGENCY OVERVIEW POTENTIAL HEALTH EFFECTS: The most serious adverse health effects associated with this product are due to ingestion
or accidental injection. ACUTE EFFECTS: INHALATION: Not considered a route of exposure. INGESTION: May be harmful if swallowed, causing gastrointestinal irritation. May also affect central nervous system
(CNS), causing anesthesia, depression, and psychological manifestations such as hallucinations. SKIN: May be irritating to the skin. If accidentally injected, may cause anesthesia at the site of injection and may cause CNS effects, including anesthesia, depression, and psychological manifestations such as hallucinations. EYES: This product is very irritating to the eyes. TARGET ORGAN EFFECTS (SUBCHROIC/CHRONIC): CNS/No chronic effects known. CARCINOGENIC EFFECTS: This product is not known to be carcinogenic. REPRODUCTIVE/TERATOGENIC EFFECTS: This product may have adverse effects on the unborn fetus and on fertility. CARCINOGENICITY STATUS: This product is not known to be carcinogenic. MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: Renal or hepatic insufficiencies. Page 1 of 4
Product Identifier: KETALEAN®
DIN #: 00612316
SECTION 5 – FIRE FIGHTING MEASURES FLASH POINT:
N/A (This product is not considered combustible.) METHOD:
N/A AUTOIGNITION TEMPERATURE:
Not established. FLAMMABILITY LIMITS:
Lower Limit: N/A Upper Limit: N/A UNUSUAL FIRE AND EXPLOSION HAZARDS:
This product may release toxic vapors when subjected to fire conditions. COMMON EXTINGUISHING METHODS:
Water spray, alcohol foam, carbon dioxide, dry chemical. FIRE FIGHTING PROCEDURES:
Fire fighters should take standard precautions when fighting fires involving this product, including the use of SCBA.
SECTION 6 – EXPOSURE CONTROLS/PERSONAL PROTECTION EXPOSURE GUIDELINES: INGREDIENT NAME
Ketamine Hydrochloride NE – Not Established
OSHA PEL/STEL
ACGIH TLV/STEL
NE/NE
NE/NE
VENTILATION:
Special ventilation provisions are not considered necessary for normal use of this product. RESPIRATORY PROTECTION:
Respiratory protection is not considered necessary for normal use of this product. PROTECTIVE GLOVES:
Latex gloves are recommended. EYE PROTECTION:
Safety glasses with side shields or safety goggles are recommended. OTHER:
N/A
SECTION 7 – PREVENTATIVE MEASURES LEAK AND SPILL PROCEDURES: For small spills (i.e. those associated with normal use of the product), wipe up spill with paper towels or other suitable materials. Rinse area with water. For large spills, contain the spill using booms, dikes, or absorbent material to prevent releases onto land or into waterways. Collect spilled material for future disposal. WASTE DISPOSAL: STORAGE AND HANDLING REQUIREMENTS: Store in a cool, dry, secure place. Keep out of the reach of children.
Page 2 of 4
Product Identifier: KETALEAN®
DIN #: 00612316
SECTION 8 – FIRST AID MEASURES Eye: Skin: Ingestion: Inhalation: Note:
Rinse eyes thoroughly with water for 15 minutes, holding eyelids apart with fingers. Contact a physician immediately. Wash affected area thoroughly with soap and water. Contact a physician. If accidentally injected, seek medical attention immediately. Seek medical attention immediately. Remove victim to fresh air. Administer oxygen if necessary. Contact a physician. For use in the field, it is advisable to carry a supply of sterile eye wash solution for emergency rinsing of eyes.
SECTION 9 – STABILITY AND REACTIVITY STABILITY:
This product is considered to be stable under normal conditions. HAZARDOUS DECOMPOSITION PRODUCTS:
This product may release toxic vapors when subjected to fire conditions. CONDITIONS TO AVOID:
Avoid exposure to excessive heat. MATERIALS AND SUBSTANCES TO AVOID (INCOMPATIBILITY):
Avoid contact with strong acids and bases.
SECTION 10 – TOXICOLOGICAL INFORMATION ACUTE DATA:
Toxicological data presented below is for the active ingredient ketamine hydrochloride. INHALATION:
Toxic by inhalation (in powdered form – injectable product is not likely to be inhaled), causing behavioral and other CNS effects. INGESTION:
Toxic by ingestion. May cause behavioral and other CNS effects. ORAL LD50 (RATS): 447 mg/Kg EYES:
Irritating to the eyes. SKIN:
May cause irritation to the skin. May be toxic if injected, causing behavioral and other CNS effects. INTRAVENOUS LD50 (RATS): 58 TARGET ORGAN EFFECTS DATA (SUBCHRONIC/CHRONIC):
CNS/No chronic effects known. CARCINOGENIC EFFECTS DATA:
This product is not known to be carcinogenic. MUTAGENIC EFFECTS DATA:
This product is not known to be mutagenic. REPRODUCTIVE/TERATOGENIC EFFECTS DATA:
This product may have adverse effects on the unborn fetus and on fertility.
SECTION 11 – TRANSPORT INFORMATION This product is not classified as a hazardous material under U.S. DOT regulations. INTERNATIONAL TRANSPORTATION REGULATIONS: This product is not classified as a hazardous material under international transportation regulations.
Page 3 of 4
Product Identifier: KETALEAN®
DIN #: 00612316
SECTION 12 – REGULATORY INFORMATION FEDERAL REGULATIONS: This product is to be used only by or on the order of a licensed veterinarian. Waste product is not classified as a hazardous waste under U.S. EPA RCRA regulations.
SECTION 13 – OTHER INFORMATION HAZARD RATINGS: NFPA*: HEALTH: 2 FLAMMABILITY: 0 REACTIVITY: 0 SPECIAL HAZARDS: NA HMIS: HEALTH: 2 FLAMMABIILTY: 0 REACTIVITY: 0 PERSONAL PROTECTION: NA * A hazard rating has not been developed by NFPA for this product. NFPA-derived rating is based on NFPA hazard evaluation criteria.
SECTION 14 – PREPARATION DATA DATE: DATE UPDATED:
TELEPHONE NUMBER:
519-654-8000
August 2002, May 2006, June 2008, August 2009, August 2010
Information for this material safety data sheet was obtained from sources considered technically accurate and reliable. While every effort has been made to ensure full disclosure of product hazards, in some cases data is not available and is so stated. Since conditions of actual product use are beyond the control of the supplier, it is assumed that user of this material has been fully trained according to the mandatory requirements of WHMIS. No warranty, expressed or implied, is made and supplier will not be liable for any losses, injuries or consequential damages which may result from the use of or reliance on any information contained in this form. If user requires independent information on ingredients in this or any other material, we recommend contact supplier.
Page 4 of 4